1077150

Amerigen Pharmaceuticals Inc. — FEI 3008849302

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 18, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lyndhurst, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)